| Pharmaceutical active ingredients: |
| Quinapril HydrochlorideQuinaprilat |
| Available forms, composition and doses of Quinazil: |
| N / A |
| Quinazil medical category: |
| Human:Angiotensin-Converting Enzyme inhibitorsAntihypertensives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C09AA06 - Quinapril |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Malesci Istituto Farmacobiologico |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Omeprazen | Omeprazole; Omeprazole Sodium | Malesci Istituto Farmacobiologico |
| Oraxim | Cefuroxime Axetil | Malesci Istituto Farmacobiologico |
| Paidomal | Lysine Theophyllinate | Malesci Istituto Farmacobiologico |
| Perventil | Albuterol; Theophylline | Malesci Istituto Farmacobiologico |
| Quinazide | Hydrochlorothiazide; Quinapril Hydrochloride | Malesci Istituto Farmacobiologico |
| Rapicort | Hydrocortisone Sodium Succinate | Malesci Istituto Farmacobiologico |
| Ritmocor | Quinidine Polygalacturonate | Malesci Istituto Farmacobiologico |
| Sustemial | Ferrous Gluconate | Malesci Istituto Farmacobiologico |
| Teproside | Vincamine Teprosilate | Malesci Istituto Farmacobiologico |
| Teraprost | Terazosin Hydrochloride | Malesci Istituto Farmacobiologico |